(Q44488825)
Statements
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder (English)
Eric Hollander
Lorrin M Koran
John H Greist
Haichen Yang
David Li
Luigi M Barbato